메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence

The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 7, 2025 -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and therapeutics, today announced that Volpara Health Technologies will now operate under the Lunit brand, introducing a unified global identity that merges their complementary strengths in breast health and AI innovation. This milestone builds on Lunit's 2024 acquisition of Volpara, an important step tha
- 김갑성 기자
- 2025-11-07 08:14
ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut

SUZHOU, China, Nov. 7, 2025 -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced that the Company will present one of its autoimmune and inflammation pipeline assets, CS2015 (OX40L/TSLP bispecific antibody), in the format of an ePoster plus an on-site oral presentation at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI). ACAAI is one of the most influe
- 김갑성 기자
- 2025-11-07 08:10
Australian Sleep Tech Company Launches a Smart Ring to Transform Sleep & Health - retimer Ring

ADELAIDE, Australia, Nov. 7, 2025 -- Re-Time Pty Ltd (RTPL) today announced the launch of the retimer Ring, the first smart ring solution developed by an Australian company to help people improve sleep and overall wellbeing. Building on a legacy of more than 25 years of research at Flinders University, the company widens its offering in the sleep wearable space with the retimer Ring. RTPL first gained global recognition in 2015 with its blue-green light therapy glasses, which continue to help thousands of people around the world with circadian sleep problems - delayed sleep, j
- 김갑성 기자
- 2025-11-07 07:00
Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally

SYDNEY, Nov. 7, 2025 -- Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close of its A$25 million Series B financing round. The round was led by Aviron Investment Management with continued participation from Oncology Ventures. This funding highlights the strong clinical adoption of Lumonus AI, with leading health systems across the United States, Australia, and Europe who are already integrating the platform into routine clinical care. To date, the Lumonus AI platform has supported clinicians in consulting and prescribing over
- 김갑성 기자
- 2025-11-07 06:00
Jungbunzlauer closes acquisition of Illinois facility to launch U.S. manufacturing operations

– Strategic investment enhances service to North American customers and supports rising market demand for high-quality ingredients – BASEL, Switzerland, Nov. 6, 2025 -- Jungbunzlauer, a global leader in high-quality ingredients from natural sources, today announced the successful closing of its acquisition of the production site in Thomson, Illinois from International Flavors & Fragrances, Inc. (IFF). This milestone marks Jungbunzlauer's first U.S. manufacturing facility, enhancing its ability to serve North American customers with greater proximity and responsivene
- 황정호 기자
- 2025-11-06 22:00
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

BELLEVUE, Wash., Nov. 6, 2025 -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced the key findings from a company-sponsored pilot study conducted by Woori IO, an OSR Company, in collaboration with Korea University Guro Hospital. The study, which took place from May 9 to September 12, 2023, evaluated the performance of the Glucheck blood glucose measurement system and validated its accuracy, stability, and usability across a representative participant group. Although the Clinical Study Report (CSR) for this exploratory trial was completed in 2023, Woori IO, then a
- 김갑성 기자
- 2025-11-06 21:30
KGC Launches Premium Ingredient Brand "G1899," for the Global B2B Health Ingredient Market

KGC, a Global Health Leader, Expands into the B2B Ingredient Sector with Its Standardized Premium Brand "G1899" Showcases "G1899" at the World's Largest Ingredient Exhibition, SSG 2025, Highlighting the Excellence of Red Ginseng Demonstrates KGC's Quality Management Systems and Advanced R&D Capabilities for Sourcing High-Purity Natural Ingredients Plans to Standardize Red Ginseng and Other Natural Ingredients to Bring JungKwanJang's Science-backed benefits to Global Partners SEOUL, South Korea, Nov. 6, 2025 -- Global health and wellness compa
- 김갑성 기자
- 2025-11-06 21:00
Asia Pacific liver health leaders and Ministry of Health officials unite in Taiwan to advance hepatocellular carcinoma surveillance and management

TAIPEI, Nov. 6, 2025 -- Senior health officials, clinicians, and policy leaders from across the Asia Pacific region convened in Taipei for the hepatocellular carcinoma (HCC) Leadership & Policy Forum, hosted by the APAC Liver Disease Alliance, the Taiwan Health Promotion Administration and the Taiwan National Health Insurance Administration. The event marked a pivotal moment in regional efforts to combat HCC, the most common type of liver cancer and a major public health challenge across the Asia-Pacific. During the Forum, the Alliance launched a peer-reviewed publication t
- 김갑성 기자
- 2025-11-06 19:49
Uniting Global Minds to Shape the Future of Healthcare -- The 3rd CREATE Symposium Opens in Hong Kong

HONG KONG, Nov. 6, 2025 -- In the era of artificial intelligence, the rapid advancements in AI and robotics are revolutionizing healthcare — reshaping diagnosis, treatment, and health management. How to deeply integrate these cutting-edge technologies into clinical practice, and transform innovative algorithms into tangible tools to save lives, has become a global priority. On 26 October, the 3rd Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium opened at the Hong Kong Convention and Exhibition Centre. Organized by the Centre for AI and Robotics (CAIR), H
- 김갑성 기자
- 2025-11-06 18:06
Millennium Technology Prize opens its nomination period for innovations for a better life

HELSINKI, Nov. 6, 2025 -- The world's leading innovation award, Millennium Technology Prize, will be awarded again in May 2027. The eligibility criteria of the prize have been expanded to even more future-oriented innovations that improve the well-being of humankind and the planet and stimulate further research and development. The global call for nominations will be open for groundbreaking innovations between 6 November 2025 and 27 February 2026. The Millennium Technology Prize is the pre-eminent one-million-euro award focused on technological innovations for a better life. The winnin
- 김갑성 기자
- 2025-11-06 16:15

이전

91 92 93 94 95 96 97 98 99 100

많이 본 기사

최근기사

2026-03-03_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 13시 40분